Private and public hospitals need thousands of medical professionals in their frontline fight to care for the surging number of coronavirus infected patients. Where are military medical personnel deployed now?
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound down.
GenMark Diagnostics stock shot up on Friday after the company announced that the FDA has issued an Emergency Use Authorization for the company’s ePlex SARS-CoV-2 test.
People who have tested positive for coronavirus should avoid using cannabis products according to research firm Aurelius Data.
Amarin has been right in the middle of this recent market sell-off, and while shares have been halved, the stock could be poised for a strong recovery. All the pieces seem to be there.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
BioNTech stock jumped on Tuesday and went even higher early on Wednesday. This comes after the company announced a collaboration with the pharmaceutical giant Pfizer.
A recent survey of U.S. adults shows rising concern over the spread of COVID-19 in the United States. Those worries extend to concerns about a possible recession.
Aytu Bioscience stock has had investors on a roller-coaster over the past week. The commercial-stage specialty pharmaceutical company has a COVID-19 test kit, but it's not the only one.
Tilray chose perhaps the worst time that it could to raise capital, as the prior trading day was the worst one that the markets have seen since the 1987 crash.
Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials often fail, so investors need to gamble that one or more of its treatments…
he World Health Organization now has upgraded the COVID-19 outbreak to pandemic status, as the cases outside of China have risen exponentially in the past two weeks.
The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical stocks decreased.
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
It is not a new scenario where an illness or problem starts to become a big deal in the public and there is a small-cap company that “has a solution for that” which happen…
